The invention relates to prodrug compounds disclosed as structural formula 1, a pharmaceutical composition and a preparation method thereof, and application of the compounds or composition thereof in preparing drugs for treating medicable states of non-steroid anti-inflammatory agents in humans or animals. The invention also discloses a transdermal therapy application system comprising the compounds or pharmaceutical composition thereof.